Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Studies advance knowledge in breast cancer research
March 9th, 2006
Breast cancer research advances have been reported from the United States, Canada and Spain. Study 1: Cyclophosphamide, methotrexate, and fluorouracil (CMF) was compared to cyclophosphamide, doxorubicin, and fluorouracil (CAF) with and without tamoxifen (TAM). According to recent research from the United States, "We evaluated the efficacy of CMF versus CAF in node-negative breast cancer patients with and without TAM, overall and by hormone receptor (HR) status. Node-negative patients identified by tumor size (>2 cm), negative HR, or high S-phase fraction (n=2,690) were randomly assigned to CMF, CAF, CMF + TAM (CMFT), or CAF + TAM (CAFT). Cox...
Source: Women's Health Weekly (2006-03-09)
|
